Graham Capital Management, L.P.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1315421 ROWAYTON, CT

Position in FULC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$91,745

-$236,078 QoQ

Shares Held

25,067

-41.4% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#94

of 154 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. FULC ranks #55 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	446,696	$25,376,799
2	INCY	Incyte Corp	15,632	$1,772,043
3	IONS	Ionis Pharmaceuticals Inc	16,717	$1,325,490
4	VKTX	Viking Therapeutics, Inc.	22,114	$862,667
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,256	$679,123
6	ARVN	Arvinas, Inc.	81,364	$676,134
7	PCVX	Vaxcyte, Inc.	11,107	$645,649
8	MRVI	Maravai Lifesciences Holdings, Inc.	92,277	$575,808

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$91,745	25,067	-41.4%	Shares	Sole	2026-08-14
2026-03-31	$327,823	42,741	-11.8%	Shares	Sole	2026-05-15
2025-12-31	$548,127	48,464	+59.0%	Shares	Sole	2026-02-17
2025-09-30	$280,471	30,486	+153.0%	Shares	Sole	2025-11-14
2025-06-30	$82,917	12,052	-92.8%	Shares	Sole	2025-08-14
2025-03-31	$478,779	166,243	+14.7%	Shares	Sole	2025-05-15
2024-12-31	$681,227	144,942	+58.9%	Shares	Sole	2025-02-14
2024-09-30	$325,641	91,216	+670.1%	Shares	Sole	2024-11-14
2023-09-30	$52,591	11,845	-62.9%	Shares	Sole	2023-11-22
2023-06-30	$105,428	31,948	-78.3%	Shares	Sole	2023-08-14
2023-03-31	$418,890	146,979	+588.3%	Shares	Sole	2023-05-15
2022-12-31	$155,449	21,353	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.